BofA/Merrill Lynch Starts Aegerion Pharmaceuticals (AEGR) at Buy

March 5, 2013 7:13 AM EST Send to a Friend
Get Alerts AEGR Hot Sheet
Price: $30.66 -7.76%

Rating Summary:
    14 Buy, 1 Hold, 1 Sell

Rating Trend: Up Up

Today's Overall Ratings:
    Up: 24 | Down: 28 | New: 14
Trade AEGR Now!
Join SI Premium – FREE
BofA/Merrill Lynch initiates coverage on Aegerion Pharmaceuticals (NASDAQ: AEGR) with a Buy. PT $39.00.

For an analyst ratings summary and ratings history on Aegerion Pharmaceuticals click here. For more ratings news on Aegerion Pharmaceuticals click here.

Shares of Aegerion Pharmaceuticals closed at $32.52 yesterday.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

New Coverage

Related Entities

Merrill Lynch, Bank of America

Add Your Comment